Glycoprotein (GP) inhibitors are indicated for the treatment of 1. acute coronary syndromes. 2. unstable angina. 3. deep vein thrombosis. 4. hypertension. 5. patients undergoing percutaneous coronary intervention (PCI)
a. 5 only
b. 1, 2, and 5 only
c. 1, 2, 4, and 5 only
d. 1, 2, 3, 4, and 5
ANS: B
Health Professions